Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males
Examining the Impact of Acute Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males: A Randomized Cross-over Trial
2 other identifiers
interventional
13
1 country
1
Brief Summary
This crossover study investigates the effects of restricting arterial blood flow during cycling exercise on PGC-1α and its upstream signalling pathways. In a randomized order, participants will exercise once for 30 minutes with restricted blood flow and then will exercise once for 30 minutes with no blood flow restriction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 19, 2018
CompletedFirst Posted
Study publicly available on registry
October 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2019
CompletedJuly 15, 2019
July 1, 2019
4 months
October 19, 2018
July 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA)
Fold-change in PGC-1α mRNA expression
15 minutes before exercise and 3 hours post-exercise for both exercise sessions
Secondary Outcomes (10)
Catecholamine concentrations
15 minutes before exercise and immediately post-exercise for both exercise sessions
Total and phosphorylated p38 mitogen-activated protein kinase (MAPK)
15 minutes before exercise and immediately post-exercise for both exercise sessions
Total and phosphorylated acetyl coenzyme A carboxylase (ACC)
15 minutes before exercise and immediately post-exercise for both exercise sessions
Total and phosphorylated protein kinase A (PKA)
15 minutes before exercise and immediately post-exercise for both exercise sessions
Acetylated p53
15 minutes before exercise and immediately post-exercise for both exercise sessions
- +5 more secondary outcomes
Study Arms (2)
CTL - BFR
EXPERIMENTALCTL Exercise then BFR Exercise
BFR - CTL
EXPERIMENTALBFR Exercise then CTL Exercise
Interventions
Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).
Participants will exercise on a recumbent bike placed on flat ground (CTL).
Eligibility Criteria
You may qualify if:
- hours of physical activity per week
- No previous cycling training
- No concurrent involvement in another training program
- Body mass index \< 30 kg/m2
You may not qualify if:
- Presence of cardiovascular disease
- Presence of metabolic disease
- Taking regular oral medication
- Current smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen's University
Kingston, Ontario, K7L3N6, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brendon J Gurd, PhD
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Allocation concealment, assessor blinding
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 19, 2018
First Posted
October 24, 2018
Study Start
October 1, 2018
Primary Completion
January 28, 2019
Study Completion
January 28, 2019
Last Updated
July 15, 2019
Record last verified: 2019-07